Caricamento...
Systemic therapy for hepatocellular carcinoma
Optimal treatment of hepatocellular carcinoma (HCC) is clinically challenging. Systemic treatment for advanced HCC was limited until the approval of sorafenib. This discovery resulted in the advent of many clinical trials. An ongoing Phase III trial is examining the benefit of adjuvant sorafenib. Ut...
Salvato in:
| Pubblicato in: | Hepat Oncol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6114012/ https://ncbi.nlm.nih.gov/pubmed/30190939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep.13.10 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|